111 related articles for article (PubMed ID: 6745168)
1. Further studies of the mineralocorticoid activity of 19-oxo-deoxycorticosterone.
Kenyon CJ; Saccoccio NA; Morris DJ
Endocrinology; 1984 Aug; 115(2):535-7. PubMed ID: 6745168
[TBL] [Abstract][Full Text] [Related]
2. Comparison of the mineralocorticoid activity of 19-oxygenated and 19-nor derivatives of deoxycorticosterone.
Melby JC; Griffing GT; Holbrook M; Wilson TE; Johnston JO
Steroids; 1991 Nov; 56(11):552-7. PubMed ID: 1814021
[TBL] [Abstract][Full Text] [Related]
3. 5 alpha-Dihydro-11-deoxycorticosterone as a mineralocorticoid agonist and antagonist: evidence for a weak mineralocorticoid as an antagonist of potent mineralocorticoids.
Sekihara H; Yazaki Y
J Steroid Biochem Mol Biol; 1993 Apr; 45(4):235-8. PubMed ID: 8499332
[TBL] [Abstract][Full Text] [Related]
4. New mineralocorticoids: 5alpha-dihydroaldosterone and 5alpha-dihydro-11-deoxycorticosterone.
Sekihara H; Island DP; Liddle GW
Endocrinology; 1978 Oct; 103(4):1450-2. PubMed ID: 744157
[TBL] [Abstract][Full Text] [Related]
5. 19-Nor deoxycorticosterone (19-nor DOC): mineralocorticoid receptor affinity higher than aldosterone, electrolyte activity lower.
Funder JW; Mercer J; Ingram B; Feldman D; Wynne K; Adam WR
Endocrinology; 1978 Oct; 103(4):1514-7. PubMed ID: 744165
[TBL] [Abstract][Full Text] [Related]
6. Mineralo- and glucocorticoid effects on renal excretion of electrolytes.
Campen TJ; Vaughn DA; Fanestil DD
Pflugers Arch; 1983 Oct; 399(2):93-101. PubMed ID: 6647008
[TBL] [Abstract][Full Text] [Related]
7. The "mineralocorticoid-like" actions conferred on corticosterone by carbenoxolone are inhibited by the mineralocorticoid receptor (type I) antagonist RU28318.
Souness GW; Morris DJ
Endocrinology; 1991 Nov; 129(5):2451-6. PubMed ID: 1657575
[TBL] [Abstract][Full Text] [Related]
8. Mineralocorticoid activity of 19-hydroxyaldosterone, 19-nor-aldosterone, and 3 beta-hydroxy-delta 5-aldosterone: relative potencies measured in two bioassay systems.
Morris DJ; Brem AS; Saccoccio NA; Pacholski M; Harnik M
Endocrinology; 1986 Jun; 118(6):2505-9. PubMed ID: 3084221
[TBL] [Abstract][Full Text] [Related]
9. Antinatriuretic and kaliuretic activities of the reduced derivatives of aldosterone.
Kenyon CJ; Brem AS; McDermott MJ; Deconti GA; Latif SA; Morris DJ
Endocrinology; 1983 May; 112(5):1852-6. PubMed ID: 6403339
[TBL] [Abstract][Full Text] [Related]
10. Effect of administered mineralocorticoids or ACTH in pregnant women. Attenuation of kaliuretic influence of mineralocorticoids during pregnancy.
Ehrlich EN; Lindheimer MD
J Clin Invest; 1972 Jun; 51(6):1301-9. PubMed ID: 4336938
[TBL] [Abstract][Full Text] [Related]
11. Mineralocorticoid activity of 19-nor-DOC and 19-OH-DOC in adrenalectomized rat.
Perrone RD; Bengele HH; Dale SL; Melby JC; Alexander EA
Am J Physiol; 1982 May; 242(5):E305-8. PubMed ID: 7081431
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of aldosterone-induced antinatriuresis and kaliuresis by actinomycin D.
Horisberger JD; Diezi J
Am J Physiol; 1984 Feb; 246(2 Pt 2):F201-4. PubMed ID: 6696121
[TBL] [Abstract][Full Text] [Related]
13. 19-Oxo-deoxycorticosterone binds to the renal mineralocorticoid receptor and produces sodium retention but not potassium excretion.
Thomas CJ; Gomez-Sanchez CE; Marver D; Gomez-Sanchez EP
Endocrinology; 1983 Aug; 113(2):517-22. PubMed ID: 6307643
[No Abstract] [Full Text] [Related]
14. Glucocorticoid inhibition of mineralocorticoid action in the rat.
Kenyon CJ; Saccoccio NA; Morris DJ
Clin Sci (Lond); 1984 Sep; 67(3):329-35. PubMed ID: 6380888
[TBL] [Abstract][Full Text] [Related]
15. The antinatriuretic and kaliuretic effects of the glucocorticoids corticosterone and cortisol following pretreatment with carbenoxolone sodium (a liquorice derivative) in the adrenalectomized rat.
Souness GW; Morris DJ
Endocrinology; 1989 Mar; 124(3):1588-90. PubMed ID: 2917528
[TBL] [Abstract][Full Text] [Related]
16. Sodium-potassium ATPase in deoxycorticosterone-salt hypertension: opposing effects of sodium load and mineralocorticoids.
Stern N; Beck FW; Vlachakis N; Eggena P; Sowers JR
Endocrinology; 1984 Feb; 114(2):624-8. PubMed ID: 6317363
[TBL] [Abstract][Full Text] [Related]
17. Effect of 6-dehydro-DOCA and 6-dehydro-9 alpha-fluorocortisol acetate on the excretion of sodium and potassium in the rat.
Genard P; Palem-Vliers M
J Steroid Biochem; 1985 Nov; 23(5A):673-5. PubMed ID: 4079383
[TBL] [Abstract][Full Text] [Related]
18. Affinity of 18,19-dihydroxydeoxycorticosterone and 18-hydroxy-19-nor-deoxycorticosterone to aldosterone receptor and their mineralocorticoid activity.
Okamoto M; Momoi K; Yamano T; Nakamura M; Odaguchi K; Shimizu T; Okada T; Terasawa T
Biochem Int; 1983 Dec; 7(6):687-94. PubMed ID: 6237653
[TBL] [Abstract][Full Text] [Related]
19. Are we missing a mineralocorticoid in teleost fish? Effects of cortisol, deoxycorticosterone and aldosterone on osmoregulation, gill Na+,K+ -ATPase activity and isoform mRNA levels in Atlantic salmon.
McCormick SD; Regish A; O'Dea MF; Shrimpton JM
Gen Comp Endocrinol; 2008 May; 157(1):35-40. PubMed ID: 18462736
[TBL] [Abstract][Full Text] [Related]
20. Progestogens with antimineralocorticoid activity.
Losert W; Casals-Stenzel J; Buse M
Arzneimittelforschung; 1985; 35(2):459-71. PubMed ID: 4039568
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
